FIELD: medicine.
SUBSTANCE: method comprises measurement of CAPRIN-1 expression level expressed on a cell surface in a biological sample by an "antigen-antibody" reaction using an antibody or an antigen-binding fragment thereof having immunological reactivity with a polypeptide having the amino acid sequence set forth in SEQ ID NO: 66. The group of inventions also relates to a drug for cancer diagnosis comprising an antibody having immunological reactivity with a polypeptide having the amino acid sequence set forth in SEQ ID NO: 66 or an antigen-binding fragment of the antibody; a kit for cancer diagnosis containing the said antibody.
EFFECT: detection of cancer.
17 cl, 6 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CANCER DETECTION | 2013 |
|
RU2646466C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2607366C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2598258C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2597971C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER | 2011 |
|
RU2567657C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2603742C2 |
IMMUNITY INDUCING AGENT | 2013 |
|
RU2639518C2 |
IMMUNITY INDUCING AGENT | 2009 |
|
RU2511039C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2641260C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT OR PREVENTION | 2013 |
|
RU2631804C2 |
Authors
Dates
2018-03-05—Published
2013-07-19—Filed